Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GNMSF - BioMarin: An Undervalued Leader With Multiple Catalysts In 2021

GNMSF - BioMarin: An Undervalued Leader With Multiple Catalysts In 2021

Genmab A/S Dkk
  • BioMarin is a leader in rare disease therapy discovery with multiple competitive advantages including scale, expertise, patents and relationships.
  • Two major catalysts for 2021 provide investors with favorable risk/reward skew afforded by a low share price that should not be ignored.
  • The company announced that 2-year data from the Phase 3 study of vosoritide will also be released in early 2021 in addition to Roctavian Phase 3.

For further details see:

BioMarin: An Undervalued Leader With Multiple Catalysts In 2021
Stock Information
Company Name: Genmab A/S Dkk
Stock Symbol: GNMSF
Market: OTC
Website: genmab.com
Menu
GNMSF GNMSF Quote GNMSF Short GNMSF News GNMSF Articles GNMSF Message Board
Get GNMSF Alerts

News, Short Squeeze, Breakout and More Instantly...